Increased cerebrospinal fluid pressure during therapy for diabetic acidosis.
D000328:Adult; D000429:Alcohol Oxidoreductases / Q000378:metabolism; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001921:Brain / Q000201:enzymology; D001929:Brain Edema / Q000209:etiology; D002245:Carbon Dioxide; D002555:Cerebrospinal Fluid; D016883:Diabetic Ketoacidosis / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000378:metabolism / Q000628:therapy*; D004285:Dogs; D005260:Female; D005632:Fructose / Q000096:biosynthesis; D006801:Humans; D006943:Hyperglycemia / Q000628:therapy; D007263:Infusions, Parenteral; D007328:Insulin / Q000627:therapeutic use; D007427:Intracranial Pressure; D008297:Male; D009994:Osmolar Concentration; D010313:Partial Pressure; D013012:Sorbitol / Q000096:biosynthesis; D014882:Water-Electrolyte Balance
D001786:Blood Glucose; D007328:Insulin; D002245:Carbon Dioxide; D005632:Fructose; D013012:Sorbitol; D000429:Alcohol Oxidoreductases